Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Elevance To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $100,000 in Elevance between April 18, 2024 and October 16, 2024 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK, July 06, 2025 (GLO ...

⚡️ TODAY: Vitalik and Wahrstätter co-authored EIP-7983 to cap Ethereum transaction gas at 16.77M.It aims to reduce DoS risk, improve zkVM, and balance gas use. https://t.co/4tF48AwX0p ...

Core Viewpoint - Rosen Law Firm is reminding investors who purchased Krispy Kreme, Inc. securities between February 25, 2025, and May 7, 2025, of the July 15, 2025, deadline to become a lead plaintiff in a class action lawsuit [1]. Group 1: Class Action Details - Investors who bought Krispy Kreme securities during the specified Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [1]. - A class action lawsuit has already been filed, and interested parties must move the Court by July 15, 2025, to serve as lead plaintiff, representing other class members [2]. Group 2: Rosen Law Firm's Credentials - Rosen Law Firm emphasizes the importance of selecting qualified counsel with a successful track record in securities class actions, highlighting its own achievements, including the largest securities class action settlement against a Chinese company at the time [3]. - The firm has been ranked No. 1 for securities class action settlements in 2017 and has consistently ranked in the top 4 since 2013, recovering hundreds of millions of dollars for investors, including over $438 million in 2019 alone [3]. Group 3: Case Allegations - The lawsuit alleges that during the Class Period, Krispy Kreme made false and misleading statements regarding the demand for its products at McDonald's locations, which declined significantly after the initial marketing launch [4]. - It is claimed that the partnership with McDonald's was not profitable, leading to a pause in expansion into new locations and that the positive statements made by Krispy Kreme were materially misleading [4].

Core Viewpoint - Rosen Law Firm is reminding investors who purchased securities of Iovance Biotherapeutics, Inc. during the specified Class Period of the upcoming lead plaintiff deadline on July 14, 2025, for a class action lawsuit [1][2]. Group 1: Class Action Details - Investors who purchased Iovance securities between May 9, 2024, and May 8, 2025, may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [1]. - A class action lawsuit has already been filed, and interested parties must move the Court to serve as lead plaintiff by July 14, 2025 [2]. - The lawsuit alleges that Iovance made false and misleading statements regarding the effectiveness of its sales team and new Authorized Treatment Centers (ATCs), which led to higher costs and lower revenue [3]. Group 2: Allegations Against Iovance - The lawsuit claims that new ATCs faced longer timelines to begin treating patients, and the sales team was ineffective in patient identification and selection, resulting in higher patient drop-offs [3]. - These dynamics contributed to a situation where ATCs could not keep pace with manufactured products, leading to misleading positive statements about Iovance's business and operations [3]. Group 3: Rosen Law Firm's Credentials - Rosen Law Firm emphasizes the importance of selecting qualified counsel with a successful track record in securities class actions, highlighting its own achievements in recovering hundreds of millions for investors [4]. - The firm has been recognized for its performance in securities class action settlements, including a notable settlement of over $438 million in 2019 [4].

An authorized transaction is a debit or credit card purchase for which the merchant has received approval from the bank that issued the customer’s payment card. https://t.co/Dt6Epw44XX ...

RT BBC Breaking News (@BBCBreaking)More than 20 people arrested after London protest in support of banned group Palestine Action, police say https://t.co/7q2XCnqImb ...

Group 1 - The article emphasizes the focus on mispriced opportunities within the financial and technology sectors, highlighting the potential for asymmetric setups driven by market overreactions, business model shifts, or cyclical inflections [1] - The author manages their own portfolio and aims to clarify their thinking while sharing high-conviction ideas that are supported by in-depth research [1]

Israel’s attacks have left gaping holes in Shia power structures and triggered a series of chain reactions https://t.co/4dWmMlgfhQ ...

NEW YORK, July 04, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) between February 27, 2025 and May 26, 2025, both dates inclusive (the “Class Period”), of the important August 11, 2025 lead plaintiff deadline. SO WHAT: If you purchased Rocket Pharmaceuticals securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a conti ...

Why try swing trading an asset with price action like this?Watcher.Guru (@WatcherGuru):Bitcoin Price on 4th of July2010: $0.012011: $152012: $72013: $772014: $6402015: $2602016: $6702017: $2,6002018: $6,5802019: $11,7652020: $9,0802021: $34,9752022: $19,7502023: $31,0502024: $58,6602025: $108,100 https://t.co/jedYEg7kPc ...